SDIX LLC - An OriGene Company Email Format
Biotechnology ResearchDelaware, United States201-500 Employees
SDIX LLC, an OriGene Company, operates in the biotechnology research space from its base in Newark, Delaware. As a wholly owned subsidiary of OriGene Technologies, it focuses on high-quality, large-scale antibody production under GMP, with every manufacturing site certified to ISO 13485:2016 and production conducted in the United States. The company's catalog includes critical immunoreagents such as Troponin I, Strep A, CRP, Apo A1, Apo B, Micro-albumin, immunoglobulins, and human serum calibrators. In addition to off-the-shelf products, SDIX offers contract manufacturing across multiple species and capacity for large-scale in vitro monoclonal and polyclonal antibody production. Its clients include research institutions and biopharmaceutical developers seeking domestically produced antibodies and related reagents to support assay development and quality control.